Ae Wealth Management LLC Vertex Pharmaceuticals Inc Transaction History

Ae Wealth Management LLC

$9.03 Billion
Q2 2024

A detailed history of Ae Wealth Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ae Wealth Management LLC holds 1,167 shares of VRTX stock, worth $586,359. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,167

Previous 1,333 12.45%

Holding current value

$586,359

Previous $557,000 1.97%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$392.81 - $485.53 $65,206 - $80,597	-166 Reduced 12.45%	1,167 $546,000
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $8.67 Million - $9.49 Million	-21,275 Reduced 94.1%	1,333 $557,000
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $586,530 - $702,262	1,710 Added 8.18%	22,608 $9.2 Million
Q3 2023 Oct 11, 2023	BUY	$338.18 - $362.46 $1.47 Million - $1.58 Million	4,351 Added 26.29%	20,898 $7.27 Million
Q2 2023 Jul 10, 2023	BUY	$314.42 - $351.91 $4.63 Million - $5.18 Million	14,732 Added 811.68%	16,547 $5.82 Million
Q1 2023 Apr 14, 2023	SELL	$283.23 - $323.1 $900,954 - $1.03 Million	-3,181 Reduced 63.67%	1,815 $571,000
Q4 2022 Jan 31, 2023	BUY	$285.76 - $321.48 $1.02 Million - $1.14 Million	3,552 Added 245.98%	4,996 $1.44 Million
Q3 2022 Oct 25, 2022	BUY	$273.83 - $305.53 $62,159 - $69,355	227 Added 18.65%	1,444 $418,000
Q2 2022 Aug 03, 2022	BUY	$234.96 - $292.55 $63,674 - $79,281	271 Added 28.65%	1,217 $343,000
Q1 2022 Apr 18, 2022	BUY	$221.42 - $260.97 $209,463 - $246,877	946 New	946 $247,000
Q3 2021 Nov 01, 2021	SELL	$181.39 - $202.99 $186,287 - $208,470	-1,027 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$187.49 - $221.1 $2.21 Million - $2.61 Million	-11,804 Reduced 92.0%	1,027 $207,000
Q1 2021 Apr 27, 2021	BUY	$207.02 - $241.31 $2.44 Million - $2.84 Million	11,782 Added 1123.16%	12,831 $2.76 Million
Q4 2020 Feb 01, 2021	SELL	$207.01 - $276.09 $694,518 - $926,281	-3,355 Reduced 76.18%	1,049 $248,000
Q3 2020 Nov 06, 2020	BUY	$255.65 - $303.1 $539,677 - $639,844	2,111 Added 92.06%	4,404 $1.2 Million
Q2 2020 Aug 05, 2020	SELL	$225.48 - $295.8 $404,736 - $530,961	-1,795 Reduced 43.91%	2,293 $666,000
Q1 2020 May 07, 2020	BUY	$199.77 - $247.81 $464,265 - $575,910	2,324 Added 131.75%	4,088 $973,000
Q4 2019 Jan 15, 2020	BUY	$166.71 - $223.91 $294,076 - $394,977	1,764 New	1,764 $386,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.

Account

Ae Wealth Management LLC Vertex Pharmaceuticals Inc Transaction History